Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MoonLake Immunotherapeutics (MLTX) Other Working Capital Changes (2021 - 2026)

MoonLake Immunotherapeutics' Other Working Capital Changes history spans 6 years, with the latest figure at -$389000.0 for Q1 2026.

  • Quarterly Other Working Capital Changes fell 42.49% to -$389000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.3 million through Mar 2026, down 111.35% year-over-year, with the annual reading at -$1.2 million for FY2025, 109.48% down from the prior year.
  • Other Working Capital Changes came in at -$389000.0 for Q1 2026, down from -$377000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $8.2 million in Q3 2024 to a low of -$3.2 million in Q4 2022.
  • The 5-year median for Other Working Capital Changes is -$171000.0 (2025), against an average of $641622.1.
  • The largest YoY upside for Other Working Capital Changes was 12808.36% in 2022 against a maximum downside of 37766.59% in 2022.
  • MoonLake Immunotherapeutics' Other Working Capital Changes stood at -$3.2 million in 2022, then surged by 96.73% to -$104168.0 in 2023, then soared by 5255.13% to $5.4 million in 2024, then tumbled by 107.02% to -$377000.0 in 2025, then fell by 3.18% to -$389000.0 in 2026.
  • Per Business Quant, the three most recent readings for MLTX's Other Working Capital Changes are -$389000.0 (Q1 2026), -$377000.0 (Q4 2025), and -$401000.0 (Q3 2025).